66

Neuro clinics 21- stroke case discussion

Embed Size (px)

DESCRIPTION

ischemic and hemorrhagic stroke

Citation preview

Page 1: Neuro clinics 21- stroke case discussion
Page 2: Neuro clinics 21- stroke case discussion

Neuro-clinics 21

Dr Pratyush Chaudhuri

Supported by Nirmal clinics & Mankind Pharmaceuticals

Page 3: Neuro clinics 21- stroke case discussion

CASE DISCUSSIONAcute Ischemic StrokeIntra-cerebral hemorrhage

Dr Pratyush Chaudhuri

Page 4: Neuro clinics 21- stroke case discussion

Case 1 A 53-year-old man with a history of hypertension was

brought to the hospital after his employer noticed that he had difficulty with speech, ambulation, and vision. 

The employer told the doctors that the patient usually left his house at 3:40 pm and arrived at work by 4:00 pm; however, no one saw him arrive at work and no time clock is used. 

The autorickshaw was called at about 5:00 pm.  He was noted to be lethargic on transport.  

Page 5: Neuro clinics 21- stroke case discussion

Has he had a stroke syndrome ??

Page 6: Neuro clinics 21- stroke case discussion

What was the time of onset of the stroke? 

Before 3.40pm 3:40 pm 4:00 pm 5:00 pm

Page 7: Neuro clinics 21- stroke case discussion

Stroke - clinical term acute loss of circulation to an area of the

brain ischemia corresponding loss of neurologic function.

Classified

hemorrhagic ischemic

Page 8: Neuro clinics 21- stroke case discussion
Page 9: Neuro clinics 21- stroke case discussion

focal neurologic deficits sudden onset

weakness

sensory deficit

difficulties with language

Page 10: Neuro clinics 21- stroke case discussion

recognition of stroke in prioritizing - for rapid transport to the

hospital

Cincinnati prehospital stroke scale defines 3 major physical findings facial droop arm weakness speech abnormalities

Page 11: Neuro clinics 21- stroke case discussion

Sudden numbness or weakness of face, arm, or leg, especially on one side of the body

Sudden confusion, difficulty in speaking or understanding

Sudden deterioration of vision of one or both eyes Sudden difficulty in walking, dizziness, and loss of

balance or coordination Sudden, severe headache with no known cause

Page 12: Neuro clinics 21- stroke case discussion

Common signs of stroke

Acute hemiparesis or hemiplegia Complete or partial hemianopia, monocular or

binocular visual loss, or diplopia Dysarthria or aphasia Ataxia, vertigo, or nystagmus Sudden decrease in consciousness

Page 13: Neuro clinics 21- stroke case discussion

Differential diagnosis Intracranial Abscess

BotulismEncephalitisHyperglycemiaHypertensive urgency/emergencyHypoglycemiaPsychiatric disorders/conversion disorderSeizureSpinal injuryUremiaIngestions (eg, ethanol)Intracranial neoplasm

Page 14: Neuro clinics 21- stroke case discussion

Why is time important?

Reperfusion strategies

improve blood flow and limit size of infarct

Page 15: Neuro clinics 21- stroke case discussion

What to do ??

Page 16: Neuro clinics 21- stroke case discussion
Page 17: Neuro clinics 21- stroke case discussion

Emergency dept protocol for presumed stroke Monitor and observe vitals every 15 mins Cardiac and O2 monitoring SOS ABC IV access - 2 peripheral lines – start 0.9 % NS at 50ml / hr thru 1 line ,

block other Stat labs –glucose, CBC, platelets, PT, aPTT, urine pregnancy test, toxic screen,

chemistry profile Wt. of pt. Stat CT head – no contrast No aspirin, other antiplatelets, heparin or warfarin till further

orders

Page 18: Neuro clinics 21- stroke case discussion

CT Easily available Exquisitely sensitive for ICH

Normal brain – 35 HU

Grey matter – 39 HU

White matter – 32 HU

IV contrast not useful in 1st 24 hrs even though BBB brokenEnhancement seen after 72 hrs

Page 19: Neuro clinics 21- stroke case discussion

early infarction signs on CT sensitivity is poorer

than

the specificity

in other words

signs are not generally well detected

but when seen, they are likely to be present.

60% CT’s normal31 % misinterpreted

Page 20: Neuro clinics 21- stroke case discussion

Hypoattenuation in thirds of middle cerebral artery territory

Obscuration of lentiform nucleus

Cortical sulcal effacement

Loss of insular ribbon, obscuration of sylvian fissure

Hyperattenuation of vessel – hyperdense MCA sign – poor outcome

Loss of gray and white matter differentiation

Hypoattenuation (measured in Hounsfield units) in basal ganglia

Page 21: Neuro clinics 21- stroke case discussion

Loss of gray-white differentiation in the posterior aspect of the right frontal lobe

Page 22: Neuro clinics 21- stroke case discussion

The scan exhibits subtle, hyperacute ischemic changes, including effacement of the insular ribbon and lentiform nucleus edema of the right hemisphere.

Page 23: Neuro clinics 21- stroke case discussion

The hyperdense middle cerebral artery sign

Page 24: Neuro clinics 21- stroke case discussion
Page 25: Neuro clinics 21- stroke case discussion

Irreversible injury - Early mass effect and areas of hypodensity -- at higher risk of hemorrhage if given thrombolytics.

Significant hypodensity on the baseline scan -- question the time of onset

Hypodensity in an area greater than one third of the MCA distribution - considered a relative contraindication for thrombolytics

Page 26: Neuro clinics 21- stroke case discussion
Page 27: Neuro clinics 21- stroke case discussion
Page 28: Neuro clinics 21- stroke case discussion

Would you order an MRI?

Page 29: Neuro clinics 21- stroke case discussion
Page 30: Neuro clinics 21- stroke case discussion

MRI

Higher sensitivity for infarcts

Better for posterior fossa, lacunar infarcts and small cortical strokes

Page 31: Neuro clinics 21- stroke case discussion

MRI not easily available / need skilled interpretation

Subtle signs may not be apparent in 1st 6 hrs Sulcal effacement Gyral swelling

Earliest signal intensity change in grey matter- white matter may be normal for 24 hrs

FLAIR sequences – optimise conspicuity - only abnormal areas are hyperintense

Page 32: Neuro clinics 21- stroke case discussion

Diffusion-weighted MRI (DW-MRI) - detects ischemic brain injury earlier than standard T1/T2-weighted MRI images or CT

scan Perfusion MRI (PW-MRI) – inject contrast material to

show areas of decreased perfusion.

Together yields areas of diffusion-weighted imaging/perfusion-

weighted imaging (DW-MRI/PW-MRI) mismatch, -- identifying potentially salvageable tissues.

MRA - noninvasive / no contrast material.

shows vascular anatomy and occlusive disease

IV contrast (Gado) needed to determine age of infarct

Page 33: Neuro clinics 21- stroke case discussion

Imaging developments for thrombolytic therapy in stroke magnetic resonance imaging

Concept of ischaemic umbra and penumbra translated to diffusion weighted image and perfusion weighted image on MRI.

DWI= irreversibly damaged infarct core PWI=complete area of hypoperfusion The volume difference between these two (PWI/DWI

mismatch) is a measure of the ischaemic penumbra-- the salvagable ischaemic tissue at risk for infarction

Page 34: Neuro clinics 21- stroke case discussion

MRI – rule out ICH ??

Conventional spin MRI – good for subacute and chronic haemorrhage

Not useful in hyperacute ICH

Gradient recalled echo scans (GRE) very sensitive to fresh blood

FLAIR also useful

Page 35: Neuro clinics 21- stroke case discussion

DW - MRI Depends on water molecule diffusability in acute

ischemia

Apparent diffusion constant (ADC) low in area of acute ischemia (upto 10 – 14 days)

may correleate with final infarct size

Acute and chronic ischemic changes similar on T2W and FLAIR

Returns to normal with time

Page 36: Neuro clinics 21- stroke case discussion

Should we take a break ?Should we take a break ?

Page 37: Neuro clinics 21- stroke case discussion
Page 38: Neuro clinics 21- stroke case discussion

What about a DSA ? Angio??

Page 39: Neuro clinics 21- stroke case discussion

DSA Final word - allowing for intraarterial

therapy also

But stroke risk 1- 2 % Needs special facilities Skilled operator

Page 40: Neuro clinics 21- stroke case discussion

This is the CT scan picture

What now ??

Page 41: Neuro clinics 21- stroke case discussion

Reperfusion strategiesimprove blood flow and limit size of infarct

IV thrombolytics - SK and rt-PA studied

Intraarterial thrombolytics

No benefit

More deaths and bleeds

Within 3 hrs -Class I recommendation by the American Stroke Association

Page 42: Neuro clinics 21- stroke case discussion
Page 43: Neuro clinics 21- stroke case discussion

Establishing time of onset is especially critical

Especially if - thrombolytic therapy is an option.

If the patient awakens with the symptoms,

then the time of onset is defined as the time the patient was last seen without symptoms.

3.40 pm in our ptArrived at 5 pm

Page 44: Neuro clinics 21- stroke case discussion

Inclusion criteria for IV rt-PA Age > 18 yrs

Clinical diagnosis of ischemic stroke with clear symptom onset within 3 hrs

Non contrast CT without evidence of haemorrhage

Page 45: Neuro clinics 21- stroke case discussion

Exclusion criteria -- Medical history

Prior history of ICH h/o IC neoplasm, aneurysm, AV malformation Stroke / head trauma – previous 3 months Major surgery / biopsy of parenchymal organ – preceding 14

days GI / GU bleed – preceding 21 days Recent MI - preceding 3 months Seizure at onset Known hereditary, acquired abnormal hemostasis Current use of anticoagulants with PT > 15 secs Use of heparin in previous 48 hrs - check aPTT

Page 46: Neuro clinics 21- stroke case discussion

Exclusion criteria -- Clinical examination

Neuro signs that improve rapidly

Isolated mild neuro deficits – ataxia, dysarthria, sensory loss alone

SBP > 185 mm Hg or DBP > 110 mmHg

Aggressive therapy needed to control BP

Page 47: Neuro clinics 21- stroke case discussion

Exclusion criteria -- CT / lab findings

e/o major hypodensity or sulcal effacement

( > 1/3 of MCA territory)

Platelet count < 100,000 / mm³

Blood glucose < 50 mg % or > 400 mg %

Page 48: Neuro clinics 21- stroke case discussion

Protocol for rt-PA administration Informed consent Calculate total dose as 0.9mg / kg (not > 90mg ) Give 10% as bolus over 1 minute Rest ( 90%) over 1 hr as infusion Maintain SBP < 185 mmHg and DBP < 110 mmHg Be alert for signs of ICH – sudden increase SBP,

decline in mental or neuro status, severe headache Repeat CT as necessary

Page 49: Neuro clinics 21- stroke case discussion
Page 50: Neuro clinics 21- stroke case discussion

Stroke onset>3hours—(what we routinely see…..) Role of stroke MRI in selecting patients of unknown onset

with PWI>DWI Intraarterial and vertebrobasilar thombolysis

prourokinase for acute M1/M2 occlusion with 9mg/2h within 3-6 hr. of acute MCA infarct

and upto 12 hrs in vertebrobasilar territory stroke.(PROACT I&II)--survival of 55-70%in successful recanalisation vs.0-10%in untreated/persistent basilar artery occlusion

Large MCA Territory infarcts-- preemptive craniectomy with duroplasty

Page 51: Neuro clinics 21- stroke case discussion

Pt’s BP – 200 / 110 mm Hg

Page 52: Neuro clinics 21- stroke case discussion

Candidate for thrombolysis - BP control

PretreatmentSBP >185 or DBP >110 mm Hg

Posttreatment DBP >140 mm Hg

SBP >230 mm Hg or DBP 121-140 mm Hg

SBP 180-230 mm Hg or DBP 105-120 mm Hg

Labetalol 10-20 mg IVP 1-2 doses orEnalapril 1.25 mg IVP

Sodium nitroprusside (0.5 mcg/kg/min)

Labetalol 10-20 mg IVP and consider labetalol infusion at 1-2 mg/min or nicardipine 5 mg/h IV infusion and titrate

Labetalol 10 mg IVP, may repeat and double every 10 min max 150mg

Page 53: Neuro clinics 21- stroke case discussion

No thrombolysis - BP control

DBP >140 mm Hg

SBP >220 or DBP 121-140 mm Hg or MAP >130 mm Hg

SBP< 220 mm Hg orDBP 105-120 mm Hg or MAP <130 mmHg

Sodium nitroprusside 0.5 mcg/kg/min; may reduce approximately 10-20%

Labetalol 10-20 mg IVP over 1-2 min; may repeat and double every 10 min up to maximum dose of 150 mg or nicardipine 5 mg/h IV infusion and titrate

Antihypertensive therapy indicated only if AMI, aortic dissection, severe CHF, or hypertensive encephalopathy present

Page 54: Neuro clinics 21- stroke case discussion
Page 55: Neuro clinics 21- stroke case discussion

Intensive care management Hemodynamic

monitoring No autoregulation so cerebral blood flow dependant on MBP

Reduction of BP can increase stroke size and severity

Treat only if signs of HT emergencies – encephalopathy,

retinal haemorrhage,

cardiac ischemia,

CHF,

rapidly progressive renal dysfunction

Page 56: Neuro clinics 21- stroke case discussion

Intensive care management Hemodynamic monitoring – non invasively or

invasively

Keep well hydrated

Use saline - no dextrose – avoid hyperglycemia

Page 57: Neuro clinics 21- stroke case discussion

Drugs to be avoided NTG – venodilator – raises ICP

Nifedipine and clonidine – rapid and unpredictable response

Nitroprusside – can cause vascular steal as normal vessels dilate more than abnormal vessels

Page 58: Neuro clinics 21- stroke case discussion

Drugs of choice

Labetalol

Enalapril

Nicardipine

Page 59: Neuro clinics 21- stroke case discussion

Pt lethargic , but opens eyes to call

Page 60: Neuro clinics 21- stroke case discussion
Page 61: Neuro clinics 21- stroke case discussion

Intensive care management Airway – intubation – Inability to protect airway

Inadequate gas exchangePoor prognostic sign

Beware hypotension and raised ICP during induction for intubation

Keep pO2 ~100 and PCO2 ~ 35PEEP as deemed

Page 62: Neuro clinics 21- stroke case discussion

Intensive care management

Elevated ICP - maximum reached in 3 – 5 days

Clinical signs may precede monitored ICP values – herniation due to local tissue shifts and not global increases in ICP

Raise head end 15 – 30 ºOsmotherapyInduced coma

No steroids

Page 63: Neuro clinics 21- stroke case discussion

General medical management Sedation – use short acting agents

Treat fever and infections – avoid hyperthermia

Nutrition - avoid hyperglycemia

DVT prophylaxis

Page 64: Neuro clinics 21- stroke case discussion

Secondary prevention of stroke

Aspirin - daily - 50-325 mg - an effective and inexpensive first-choice agent

Newer antiplatelet agents - clopidogrel and aspirin/dipyridamole combinations –

also effective in reducing recurrent stroke rate may cause adverse effects that must be monitored.

Warfarin as indicated

Page 65: Neuro clinics 21- stroke case discussion

Secondary prevention of stroke Hypertension

Hyperlipidemia

Diabetes mellitus

Page 66: Neuro clinics 21- stroke case discussion

That’s all folks !